Analysis of Primary Graft Dysfunction (PGD) Risk Factors in Lung Transplantation (LuTx) Patients

被引:0
|
作者
Kubisa, Michal Jan [1 ]
Wojtys, Malgorzata Edyta [2 ]
Lisowski, Piotr [2 ]
Kordykiewicz, Dawid [2 ]
Piotrowska, Maria [2 ]
Wojcik, Janusz [2 ]
Pierog, Jaroslaw [2 ]
Safranow, Krzysztof [3 ]
Grodzki, Tomasz [2 ]
Kubisa, Bartosz [4 ]
机构
[1] Carolina Hosp Luxmed, Dept Orthopaed Surg & Traumatol, PL-02757 Warsaw, Poland
[2] Pomeranian Med Univ, Dept Thorac Surg & Transplantat, PL-70880 Szczecin, Poland
[3] Pomeranian Med Univ, Dept Biochem & Med Chem, PL-70111 Szczecin, Poland
[4] Warsaw Med Univ, Dept Cardiac Thorac & Transplantat Surg, PL-02097 Warsaw, Poland
关键词
PGD; lung transplantation; CVP; CENTRAL VENOUS-PRESSURE; ISHLT WORKING GROUP; INTERNATIONAL-SOCIETY; ISCHEMIC TIME; HEART; SURVIVAL; DEFINITION; INCREASES; STATEMENT; OUTCOMES;
D O I
10.3390/clinpract14040127
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Primary graft dysfunction (PGD) is a form of acute lung injury (ALI) that occurs within 72 h after lung transplantation (LuTx) and is the most common early complication of the procedure. PGD is diagnosed and graded based on the ratio of the partial pressure of arterial oxygen to the fraction of inspired oxygen and chest X-ray results. PGD grade 3 increases recipient mortality and the chance of chronic lung allograft dysfunction (CLAD). Method: The aim of this retrospective study was to identify new PGD risk factors. The inclusion criteria were met by 59 patients, who all received transplants at the same center between 2010 and 2018. Donor data were taken from records provided by the Polish National Registry of Transplantation and analyzed in three variants: PGD 1-3 vs. PGD 0, PGD 3 vs. PGD 0 and PGD 3 vs. PGD 0-2. Results: A multiple-factor logistic regression model was used to identify decreasing recipient age; higher donor BMI and higher donor central venous pressure (CVP) for the PGD (of the 1-3 grade) risk factor. Conclusions: Longer cold ischemia time (CIT) and higher donor CVP proved to be independent risk factors of PGD 3.
引用
收藏
页码:1571 / 1583
页数:13
相关论文
共 50 条
  • [31] A Panel of Lung Injury Biomarkers Enhances the Definition of Primary Graft Dysfunction (PGD) after Lung Transplantation for Early Clinical Studies
    Shah, R. J.
    Diamond, J. M.
    Kawut, S. M.
    Lee, J. C.
    Lederer, D. J.
    Bhorade, S.
    Crespo, M.
    Demissie, E. J.
    Belperio, J. A.
    Lama, V. N.
    Orens, J. B.
    Palmer, S. M.
    Reynolds, J.
    Shah, A.
    Shah, P.
    Wille, K. M.
    Weinacker, A.
    Weill, D. S.
    Wilkes, D.
    Ware, L. B.
    Christie, J. D.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2012, 31 (04): : S103 - S103
  • [32] Primary Graft Dysfunction Increases the Risk of Baseline Lung Allograft Dysfunction but Not Chronic Lung Allograft Dysfunction after Lung Transplantation
    Li, D.
    Hirji, A.
    Weinkauf, J. G.
    Lien, D. C.
    Kapasi, A. M.
    Halloran, K.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2020, 39 (04): : S327 - S327
  • [33] Factors associated with early graft dysfunction in cystic fibrosis patients receiving primary bilateral lung transplantation
    Felten, Marie-Louise
    Sinaceur, Meriem
    Treilhaud, Michele
    Roze, Hadrien
    Mornex, Jean-Francois
    Pottecher, Julien
    Journois, Didier
    Fischler, Marc
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2012, 41 (03) : 686 - 690
  • [34] Clinical risk factors for primary graft failure following lung transplantation
    Christie, JD
    Kotloff, RM
    Pochettino, A
    Arcasoy, SM
    Rosengard, BR
    Landis, JR
    Kimmel, SE
    CHEST, 2003, 124 (04) : 1232 - 1241
  • [35] Cell-Free DNA in Human Ex-Vivo Lung Perfusate as a Potential Biomarker to Predict the Risk of Primary Graft Dysfunction (PGD) in Lung Transplantation
    Kanou, T.
    Zamel, R.
    Chen, M.
    Nakajima, D.
    Watanabe, Y.
    Ding, L.
    Azad, S.
    Waddell, T. K.
    Nakahira, K.
    Choi, A. M.
    Cypel, M.
    Liu, M.
    Keshavjee, S.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2017, 36 (04): : S187 - S187
  • [36] Histological appearances in patients with radiologically defined primary graft dysfunction (PGD)
    Burton, C. M.
    Zemtsovski, M.
    Iversen, M.
    Milman, N.
    Carlsen, J.
    Andersen, C. B.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2006, 25 (02): : S175 - S175
  • [37] Primary Graft Dysfunction After Heart Transplantation: Incidence and Current Risk Factors
    Chen, S.
    Ostberg, N. P.
    Carillo, J. A.
    Gidea, C.
    Reyentovich, A.
    Galloway, A. C.
    Moazami, N.
    Smith, D. E.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2022, 41 (04): : S368 - S368
  • [38] Recipient-Related Clinical Risk Factors for Primary Graft Dysfunction after Lung Transplantation: A Systematic Review and Meta-Analysis
    Liu, Yao
    Liu, Yi
    Su, Lili
    Jiang, Shu-Juan
    PLOS ONE, 2014, 9 (03):
  • [39] Early ECMO (extracorporeal membrane oxygenation) improves survival after severe primary graft dysfunction (PGD) in lung transplantation
    Wigfleld, C. H.
    Lindsey, J. D.
    Steffens, T. G.
    Edwards, N. M.
    Love, R. B.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2006, 25 (02): : S48 - S48
  • [40] Effects of Hyperglycemia on Primary Graft Dysfunction in Lung Transplantation
    Weir, W.
    Han, M. K.
    Shih, T. Y.
    Reddy, R. M.
    Chan, K. M.
    Chang, A. C.
    Lin, J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2013, 32 (04): : S271 - S271